Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Figure S2 from Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer
  1. Home
  2. Publications
  3. Figure S2 from Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer

Figure S2 from Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer

Authors:
  • YKYifan Kong
    Yifan Kong
  • YZYanquan Zhang
    Yanquan Zhang
  • FMFengyi Mao
    Fengyi Mao
  • ZZZhuangzhuang Zhang
    Zhuangzhuang Zhang
  • ZLZhiguo Li
    Zhiguo Li
  • RWRuixin Wang
    Ruixin Wang
  • JLJinghui Liu
    Jinghui Liu
  • XLXiaoqi Liu
    Xiaoqi Liu

Open Access
Publisher website
Google Scholar
  • 3 April 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1535-7163.22519488
Abstract
AR expressions in various cell lines & combinational effects on PC3 and DU145
Keywords
  • ANTITUMOR EFFICACY
  • PROSTATE CANCER
  • CELL LINES
  • COMBINATIONAL EFFECTS
  • FIGURE
  • ENHANCES
  • INHIBITION
  • ANTITUMOR
  • EFFICACY
  • METFORMIN
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.